Sativex long-term use: an open-label trial

A cannabis derived drug which has been approved in some countries to treat muscle spasticity.

Sativex long-term use: an open-label trial

Postby MSUK » Tue Aug 14, 2012 8:02 am

Sativex long-term use: an open-label trial in patients with spasticity due to MS

Image

Summary: This new study from a research group in Scotland assesses the long term safety profile of regular Sativex use for spasticity in MS.

The report, which follows-up 146 patients using treatment for a mean duration of 334 days, administering a mean of 7.3 actuations per day, found that 36% withdrew in the first year, either due to adverse events of lack of efficacy. Most common adverse events were fatigue and dizziness. Serious adverse events were rare and included two psychiatric events in the same patient. No serious effects were seen with abrupt withdrawal and patients did not build up a tolerance to the drug in this study....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1814
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2184
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Sativex

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service

cron